FDA Approves Pirtobrutinib for R/R Mantle Cell Lymphoma ...Middle East

Medscape - News
This drug is the first BTK inhibitor approved to treat mantle cell lymphoma in this setting. Approval was based on overall response rates and duration of response in the phase 1/2 BRUIN trial. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Pirtobrutinib for R/R Mantle Cell Lymphoma )

Apple Storegoogle play

Also on site :

Most viewed in News